As a governmental oversight agency, it should be appalling that the FDA uses experts who have financial interests in the drugs and products about which they provide expert testimony. Yet, in a study conducted by the consumer group Public Citizen, that is exactly what is happening. How can any expert provide unbiased testimony about a product in which they've bought stock or have some financial interest? That's not true oversight, but profiteering at the expense of the consumer.
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/277 .